Literature DB >> 12022264

The medical treatment of depression, 1991-1996: productive inefficiency, expected outcome variations, and price indexes.

Ernst R Berndt1, Anupa Bir, Susan H Busch, Richard G Frank, Sharon-Lise T Normand.   

Abstract

We examine the price of treating episodes of acute phase major depression over the 1991-1996 time period. We combine data from a large retrospective medical claims data base (MarketScan, from the Medstat Group) with clinical literature and expert clinical opinion elicited from a two-stage Delphi procedure. This enables us to construct a variety of treatment price indexes that include variations over time in the proportion of the "off-frontier" production, as well as the corresponding variations in expected treatment outcomes. We find that in general the incremental cost of successfully treating an episode of acute phase major depression has generally fallen over the 1991-1996 time period. Based on hedonic regression equations that account for the effects of changing patient mix, we find reductions that range from about -1.66 to -2.13% per year.

Entities:  

Mesh:

Year:  2002        PMID: 12022264     DOI: 10.1016/s0167-6296(01)00132-1

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  21 in total

1.  Setting prices for new vaccines (in advance).

Authors:  Thomas G McGuire
Journal:  Int J Health Care Finance Econ       Date:  2003-09

2.  The public costs of mental health response: lessons from the New York City post-9/11 needs assessment.

Authors:  Kathrine Jack; Sherry Glied
Journal:  J Urban Health       Date:  2002-09       Impact factor: 3.671

3.  Has the European union achieved a single pharmaceutical market?

Authors:  Aysegul Timur; Gabriel Picone; Jeffrey DeSimone
Journal:  Int J Health Care Finance Econ       Date:  2011-10-09

4.  Retention in depression treatment among ethnic and racial minority groups in the United States.

Authors:  Lisa R Fortuna; Margarita Alegria; Shan Gao
Journal:  Depress Anxiety       Date:  2010-05       Impact factor: 6.505

Review 5.  Changes in the costs of treating mental health disorders: an overview of recent research findings.

Authors:  Ernst R Berndt
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  QUALITY-CONSTANT "PRICES" FOR THE ONGOING TREATMENT OF SCHIZOPHRENIA: AN EXPLORATORY STUDY*

Authors:  Richard G Frank; Ernst R Berndt; Alisa B Busch; Anthony F Lehman
Journal:  Q Rev Econ Finance       Date:  2004-07

7.  Disparities in mental health service use of racial and ethnic minority elderly adults.

Authors:  Daniel E Jimenez; Ben Cook; Stephen J Bartels; Margarita Alegría
Journal:  J Am Geriatr Soc       Date:  2012-12-18       Impact factor: 5.562

8.  Adolescent depression: diagnosis, treatment, and educational attainment.

Authors:  Jason M Fletcher
Journal:  Health Econ       Date:  2008-11       Impact factor: 3.046

9.  Marketing depression care management to employers: design of a randomized controlled trial.

Authors:  Kathryn M Rost; Donna Marshall
Journal:  Implement Sci       Date:  2010-03-16       Impact factor: 7.327

10.  The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders.

Authors:  Alisa B Busch; Frank Yoon; Colleen L Barry; Vanessa Azzone; Sharon-Lise T Normand; Howard H Goldman; Haiden A Huskamp
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.